Chat OEC
Company Explorer
Trend Explorer
Tree map
Stacked
Network
Map
Scatter
Exports In 2022, Belgium exported $47.1B in Vaccines, blood, antisera, toxins and cultures, making it the 2nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 2nd most exported product in Belgium. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Belgium are: United States ($9.38B), Germany ($7.86B), Japan ($6.02B), United Kingdom ($2.72B), and France ($2.59B).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Belgium between 2021 and 2022 were United States ($2.29B), Japan ($1.33B), and France ($662M).
Imports In 2022, Belgium imported $20.7B in Vaccines, blood, antisera, toxins and cultures, becoming the 3rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most imported product in Belgium. Belgium imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($9.85B), France ($2.72B), United States ($1.9B), Switzerland ($1.61B), and Italy ($1.4B).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Belgium between 2021 and 2022 were Ireland ($3.91B), France ($366M), and Italy ($63.4M).
